124 related articles for article (PubMed ID: 10543981)
1. Overexpression of the alpha2,6-sialyltransferase, ST6Gal I, in a low metastatic variant of a murine lymphoblastoid cell line is associated with appearance of a unique ST6Gal I mRNA.
Lo NW; Dennis JW; Lau JT
Biochem Biophys Res Commun; 1999 Nov; 264(3):619-21. PubMed ID: 10543981
[TBL] [Abstract][Full Text] [Related]
2. Novel heterogeneity exists in the 5'-untranslated region of the beta-galactoside alpha 2,6-sialytransferase mRNAs in the human B-lymphoblastoid cell line, louckes.
Lo NW; Lau JT
Biochem Biophys Res Commun; 1996 Nov; 228(2):380-5. PubMed ID: 8920923
[TBL] [Abstract][Full Text] [Related]
3. Mouse ST6Gal sialyltransferase gene expression during mammary gland lactation.
Dalziel M; Huang RY; Dall'Olio F; Morris JR; Taylor-Papadimitriou J; Lau JT
Glycobiology; 2001 May; 11(5):407-12. PubMed ID: 11425801
[TBL] [Abstract][Full Text] [Related]
4. Murine B cell differentiation is accompanied by programmed expression of multiple novel beta-galactoside alpha2, 6-sialyltransferase mRNA forms.
Wuensch SA; Huang RY; Ewing J; Liang X; Lau JT
Glycobiology; 2000 Jan; 10(1):67-75. PubMed ID: 10570225
[TBL] [Abstract][Full Text] [Related]
5. Murine hepatic beta-galactoside alpha 2,6-sialyltransferase gene expression involves usage of a novel upstream exon region.
Hu YP; Dalziel M; Lau JT
Glycoconj J; 1997 Apr; 14(3):407-11. PubMed ID: 9147064
[TBL] [Abstract][Full Text] [Related]
6. Hepatic acute phase induction of murine beta-galactoside alpha 2,6 sialyltransferase (ST6Gal I) is IL-6 dependent and mediated by elevation of exon H-containing class of transcripts.
Dalziel M; Lemaire S; Ewing J; Kobayashi L; Lau JT
Glycobiology; 1999 Oct; 9(10):1003-8. PubMed ID: 10521536
[TBL] [Abstract][Full Text] [Related]
7. Ras oncogene induces beta-galactoside alpha2,6-sialyltransferase (ST6Gal I) via a RalGEF-mediated signal to its housekeeping promoter.
Dalziel M; Dall'Olio F; Mungul A; Piller V; Piller F
Eur J Biochem; 2004 Sep; 271(18):3623-34. PubMed ID: 15355339
[TBL] [Abstract][Full Text] [Related]
8. Transcription of the beta-galactoside alpha2,6-sialyltransferase gene (SIAT1) in B-lymphocytes: cell type-specific expression correlates with presence of the divergent 5'-untranslated sequence.
Lo NW; Lau JT
Glycobiology; 1999 Sep; 9(9):907-14. PubMed ID: 10460832
[TBL] [Abstract][Full Text] [Related]
9. Biologic contribution of P1 promoter-mediated expression of ST6Gal I sialyltransferase.
Appenheimer MM; Huang RY; Chandrasekaran EV; Dalziel M; Hu YP; Soloway PD; Wuensch SA; Matta KL; Lau JT
Glycobiology; 2003 Aug; 13(8):591-600. PubMed ID: 12672700
[TBL] [Abstract][Full Text] [Related]
10. Enhanced expression of alpha 2,6-sialyltransferase ST6Gal I in cervical squamous cell carcinoma.
Wang PH; Lee WL; Lee YR; Juang CM; Chen YJ; Chao HT; Tsai YC; Yuan CC
Gynecol Oncol; 2003 Jun; 89(3):395-401. PubMed ID: 12798701
[TBL] [Abstract][Full Text] [Related]
11. [Effects of ST6Gal I antisense oligonucleotide-mediated gene silencing on cell adhesion and invasiveness of hela cells].
Yuan TH; Li MY; Li WY; Li H; Jiang ZH
Zhonghua Zhong Liu Za Zhi; 2007 Jan; 29(1):21-4. PubMed ID: 17575688
[TBL] [Abstract][Full Text] [Related]
12. The second bovine beta-galactoside-alpha2,6-sialyltransferase (ST6Gal II): genomic organization and stimulation of its in vitro expression by IL-6 in bovine mammary epithelial cells.
Laporte B; Gonzalez-Hilarion S; Maftah A; Petit JM
Glycobiology; 2009 Oct; 19(10):1082-93. PubMed ID: 19617256
[TBL] [Abstract][Full Text] [Related]
13. Transcription of the beta-galactoside alpha 2,6-sialyltransferase gene in B lymphocytes is directed by a separate and distinct promoter.
Lo NW; Lau JT
Glycobiology; 1996 Apr; 6(3):271-9. PubMed ID: 8724135
[TBL] [Abstract][Full Text] [Related]
14. Biosynthesis of the cancer-related sialyl-alpha 2,6-lactosaminyl epitope in colon cancer cell lines expressing beta-galactoside alpha 2,6-sialyltransferase under a constitutive promoter.
Dall'Olio F; Chiricolo M; Mariani E; Facchini A
Eur J Biochem; 2001 Nov; 268(22):5876-84. PubMed ID: 11722575
[TBL] [Abstract][Full Text] [Related]
15. [Combinatorial effects of ST6Gal I siRNA and antisense oligonucleotide-mediated gene silence on metastasis ability of cervical carcinoma cells].
Yuan TH; Li MY; Li WY; Li H; Jiang ZH
Sichuan Da Xue Xue Bao Yi Xue Ban; 2007 Mar; 38(2):217-21. PubMed ID: 17441333
[TBL] [Abstract][Full Text] [Related]
16. Characterization of the second type of human beta-galactoside alpha 2,6-sialyltransferase (ST6Gal II), which sialylates Galbeta 1,4GlcNAc structures on oligosaccharides preferentially. Genomic analysis of human sialyltransferase genes.
Takashima S; Tsuji S; Tsujimoto M
J Biol Chem; 2002 Nov; 277(48):45719-28. PubMed ID: 12235148
[TBL] [Abstract][Full Text] [Related]
17. Molecular cloning, expression and exon/intron organization of the bovine beta-galactoside alpha2,6-sialyltransferase gene.
Mercier D; Wierinckx A; Oulmouden A; Gallet PF; Palcic MM; Harduin-Lepers A; Delannoy P; Petit JM; Levéziel H; Julien R
Glycobiology; 1999 Sep; 9(9):851-63. PubMed ID: 10460827
[TBL] [Abstract][Full Text] [Related]
18. Comparison of the enzymatic properties of mouse beta-galactoside alpha2,6-sialyltransferases, ST6Gal I and II.
Takashima S; Tsuji S; Tsujimoto M
J Biochem; 2003 Aug; 134(2):287-96. PubMed ID: 12966079
[TBL] [Abstract][Full Text] [Related]
19. ST6Gal-I sialyltransferase promotes chemoresistance in pancreatic ductal adenocarcinoma by abrogating gemcitabine-mediated DNA damage.
Chakraborty A; Dorsett KA; Trummell HQ; Yang ES; Oliver PG; Bonner JA; Buchsbaum DJ; Bellis SL
J Biol Chem; 2018 Jan; 293(3):984-994. PubMed ID: 29191829
[TBL] [Abstract][Full Text] [Related]
20. Clinical relevance of sialyltransferases ST6GAL-I and ST3GAL-III in gastric cancer.
Gretschel S; Haensch W; Schlag PM; Kemmner W
Oncology; 2003; 65(2):139-45. PubMed ID: 12931020
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]